CANDEL THERAPEUTICS, INC. Basic Shares Outstanding (Weighted Average)
CANDEL THERAPEUTICS, INC. (CADL) reported Basic Shares Outstanding (Weighted Average) of 74.13 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- CANDEL THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 74.13M shares, a 43.97% increase year-over-year.
- CANDEL THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 62.36M shares, a 23.53% increase year-over-year.
- CANDEL THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 54.92M shares, a 54.30% increase year-over-year.
- CANDEL THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 54.89M shares, a 71.47% increase year-over-year.
- CANDEL THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 52.96M shares, a 67.19% increase from fiscal 2024.
- CANDEL THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 31.68M shares, a 9.47% increase from fiscal 2023.
- CANDEL THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 28.94M shares, a 0.39% increase from fiscal 2022.
- CANDEL THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 28.82M shares, a 52.72% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 74.13M shares 10-Q · filed 2026-08-13 | 68.28M shares 10-Q · filed 2026-08-13 | 63.80M shares derived: average of 3 quarters · filed 2026-08-13 | 61.58M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | 62.36M shares 10-Q · filed 2026-05-14 | 58.64M shares derived: average of 2 quarters · filed 2026-05-14 | 57.39M shares derived: average of 3 quarters · filed 2026-05-14 | 55.92M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | 54.92M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 54.91M shares derived: average of 2 quarters · filed 2026-03-12 | 53.77M shares derived: average of 3 quarters · filed 2026-08-13 | 52.96M shares 10-K · filed 2026-03-12 |
| 2025-09-30 | 54.89M shares 10-Q · filed 2025-11-13 | 53.19M shares derived: average of 2 quarters · filed 2026-08-13 | 52.31M shares 10-Q · filed 2025-11-13 | 48.11M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | 51.49M shares 10-Q · filed 2026-08-13 | 50.99M shares 10-Q · filed 2026-08-13 | 45.86M shares derived: average of 3 quarters · filed 2026-08-13 | 42.39M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | 50.48M shares 10-Q · filed 2026-05-14 | 43.04M shares derived: average of 2 quarters · filed 2026-05-14 | 39.36M shares derived: average of 3 quarters · filed 2026-05-14 | 36.99M shares derived: average of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | 35.59M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 33.80M shares derived: average of 2 quarters · filed 2026-03-12 | 32.49M shares derived: average of 3 quarters · filed 2026-03-12 | 31.68M shares 10-K · filed 2026-03-12 |
| 2024-09-30 | 32.01M shares 10-Q · filed 2025-11-13 | 30.95M shares derived: average of 2 quarters · filed 2025-11-13 | 30.37M shares 10-Q · filed 2025-11-13 | 30.02M shares derived: average of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | 29.88M shares 10-Q · filed 2025-08-14 | 29.54M shares 10-Q · filed 2025-08-14 | 29.35M shares derived: average of 3 quarters · filed 2025-08-14 | 29.24M shares derived: average of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | 29.20M shares 10-Q · filed 2025-05-13 | 29.09M shares derived: average of 2 quarters · filed 2025-05-13 | 29.03M shares derived: average of 3 quarters · filed 2025-05-13 | 29.00M shares derived: average of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | 28.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | 28.95M shares derived: average of 2 quarters · filed 2025-03-13 | 28.94M shares derived: average of 3 quarters · filed 2025-03-13 | 28.94M shares 10-K · filed 2025-03-13 |
| 2023-09-30 | 28.92M shares 10-Q · filed 2024-11-14 | 28.92M shares derived: average of 2 quarters · filed 2024-11-14 | 28.92M shares 10-Q · filed 2024-11-14 | 28.91M shares derived: average of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | 28.92M shares 10-Q · filed 2024-08-13 | 28.92M shares 10-Q · filed 2024-08-13 | 28.91M shares derived: average of 3 quarters · filed 2024-08-13 | 28.91M shares derived: average of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | 28.92M shares 10-Q · filed 2024-05-14 | 28.91M shares derived: average of 2 quarters · filed 2024-05-14 | 28.90M shares derived: average of 3 quarters · filed 2024-05-14 | 28.88M shares derived: average of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | 28.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 28.90M shares derived: average of 2 quarters · filed 2024-03-28 | 28.87M shares derived: average of 3 quarters · filed 2024-03-28 | 28.82M shares 10-K · filed 2024-03-28 |
| 2022-09-30 | 28.89M shares 10-Q · filed 2023-11-09 | 28.85M shares derived: average of 2 quarters · filed 2023-11-09 | 28.80M shares 10-Q · filed 2023-11-09 | 28.79M shares derived: average of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | 28.81M shares 10-Q · filed 2023-08-10 | 28.75M shares 10-Q · filed 2023-08-10 | 28.75M shares derived: average of 3 quarters · filed 2023-08-10 | 27.40M shares derived: average of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | 28.69M shares 10-Q · filed 2023-05-11 | 28.72M shares derived: average of 2 quarters · filed 2023-05-11 | 26.92M shares derived: average of 3 quarters · filed 2023-05-11 | 23.12M shares derived: average of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | 28.75M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 26.04M shares derived: average of 2 quarters · filed 2023-03-30 | 21.27M shares derived: average of 3 quarters · filed 2023-03-30 | 18.87M shares 10-K · filed 2023-03-30 |
| 2021-09-30 | 23.33M shares 10-Q · filed 2022-11-10 | 17.52M shares derived: average of 2 quarters · filed 2022-11-10 | 15.58M shares 10-Q · filed 2022-11-10 | |
| 2021-06-30 | 11.72M shares 10-Q · filed 2022-08-05 | 11.68M shares 10-Q · filed 2022-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |